The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...

Because PAH is progressive, ongoing risk assessment is an essential part of PAH management. Once diagnosed, the overall treatment goal for people with PAH is to achieve and maintain a low-risk status ...

At Janssen, our mission is to put the needs and well-being of the people we serve as a top priority. As part of the larger healthcare ecosystem, we also recognize our responsibility to listen to and ...

Cardiovascular-outcomes-show-increased-complications-for-patients-facing-gastrointestinal-procedures-with-elevated-pulmonary-pressure ...

Suitable tools for assessing the severity of chronic obstructive pulmonary disease (COPD) include multi-component indices and the global initiative for chronic obstructive lung disease (GOLD) ...

The California Technology Assessment Forum (CTAF) is requested to review the scientific evidence for the safety and efficacy of the use of inferior vena cava (IVC) filters for the prevention of ...

COPD diagnosis Researchers have proposed that the COPD Assessment Test (CAT) be used as a US Food and Drug Administration (FDA) clinical outcomes assessment tool. Members of the COPD Biomarker ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The REVEAL Lite 2 risk assessment tool is prognostic of ...

NICE's medical technologies advisory committee considered evidence on digital technologies to deliver pulmonary rehabilitation programmes for people with chronic obstructive pulmonary disease (COPD) ...

Saliva molecular testing showed strong accuracy for pulmonary tuberculosis. Read more about this nonsputum diagnostic approach.

Medical understanding of pulmonary arterial hypertension (PAH) has come a long way in the last 20 years.1,2 Today, the medical community has a much clearer picture of the pathophysiology of this ...